Current Stem Cell Research & Therapy

Scope & Guideline

Exploring Innovative Therapies for Tomorrow's Medicine

Introduction

Welcome to the Current Stem Cell Research & Therapy information hub, where our guidelines provide a wealth of knowledge about the journal’s focus and academic contributions. This page includes an extensive look at the aims and scope of Current Stem Cell Research & Therapy, highlighting trending and emerging areas of study. We also examine declining topics to offer insight into academic interest shifts. Our curated list of highly cited topics and recent publications is part of our effort to guide scholars, using these guidelines to stay ahead in their research endeavors.
LanguageEnglish
ISSN1574-888x
PublisherBENTHAM SCIENCE PUBL LTD
Support Open AccessNo
CountryUnited Arab Emirates
TypeJournal
Convergefrom 2006 to 2024
AbbreviationCURR STEM CELL RES T / Curr. Stem Cell Res. Ther.
Frequency8 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
AddressEXECUTIVE STE Y-2, PO BOX 7917, SAIF ZONE, 1200 BR SHARJAH, U ARAB EMIRATES

Aims and Scopes

Current Stem Cell Research & Therapy focuses on advancing the understanding and therapeutic applications of stem cells across various medical domains. The journal emphasizes innovative research that explores the mechanisms, efficacy, and safety of stem cell therapies, while also addressing the challenges in regenerative medicine.
  1. Stem Cell Mechanisms and Pathways:
    Research exploring the underlying biological mechanisms of stem cells, including signaling pathways, differentiation processes, and the effects of various factors on stem cell behavior.
  2. Clinical Applications of Stem Cells:
    Studies focusing on the therapeutic applications of stem cells in treating various diseases, including but not limited to neurodegenerative disorders, cardiovascular diseases, and autoimmune conditions.
  3. Stem Cell Sources and Characteristics:
    Investigations into different sources of stem cells, such as mesenchymal stem cells, induced pluripotent stem cells, and embryonic stem cells, along with their unique properties and potential therapeutic uses.
  4. Exosomes and Secretome in Stem Cell Therapy:
    Research on the role of stem cell-derived exosomes and secretome in mediating therapeutic effects, including their potential in tissue repair and regeneration.
  5. Tissue Engineering and Regenerative Medicine:
    Studies involving the integration of stem cells with biomaterials and scaffolds to enhance tissue regeneration and repair in various medical applications.
  6. Safety and Efficacy of Stem Cell Therapies:
    Meta-analyses and systematic reviews assessing the safety, efficacy, and long-term outcomes of stem cell therapies in clinical settings.
The journal has witnessed an increase in research themes that highlight innovative approaches and emerging areas of interest in stem cell therapy. This section discusses the trending scopes that are shaping the future of the field.
  1. Exosome Research and Applications:
    There is a growing trend in the exploration of exosomes derived from stem cells, focusing on their roles in intercellular communication and potential as therapeutic agents in regenerative medicine.
  2. Combination Therapies Involving Stem Cells:
    Recent publications emphasize the use of stem cells in combination with other therapeutic modalities, such as gene therapy, nanomaterials, and pharmacological agents, to enhance treatment outcomes.
  3. Technological Advances in Stem Cell Research:
    The integration of advanced technologies, such as CRISPR gene editing, bioinformatics, and 3D bioprinting, is increasingly being recognized for its potential to revolutionize stem cell applications and tissue engineering.
  4. Personalized Medicine Approaches:
    Emerging themes highlight the personalization of stem cell therapies based on patient-specific factors, including genetic and epigenetic profiles, to optimize treatment efficacy and safety.
  5. Focus on Aging and Stem Cells:
    Research addressing the implications of aging on stem cell function and the development of therapies targeting age-related diseases is gaining momentum, reflecting an increasing interest in geriatric medicine.

Declining or Waning

As the field of stem cell research evolves, certain themes have shown a decline in prominence within the journal. This section highlights these waning scopes, which may reflect shifts in research focus or challenges in clinical application.
  1. Basic Science of Stem Cells:
    While foundational research on stem cell biology remains important, there has been a noticeable decline in publications focused solely on basic science without direct clinical implications, as the field moves towards more applied research.
  2. Non-Mesenchymal Stem Cell Applications:
    Research centered on non-mesenchymal stem cells, such as hematopoietic stem cells or embryonic stem cells, has decreased, possibly due to the increased focus on mesenchymal stem cells and their therapeutic versatility.
  3. In-vitro Studies Without Clinical Relevance:
    There has been a reduction in the publication of purely in-vitro studies that do not translate into clinical applications, as the journal emphasizes studies that demonstrate clear potential for therapeutic use.
  4. Single-source Stem Cell Studies:
    Research focusing on single-source stem cells (e.g., only one type of stem cell) is less common, reflecting a shift towards comparative studies that assess multiple stem cell types and sources for broader therapeutic implications.

Similar Journals

MOLECULAR MEDICINE

Empowering Research through Open Access Insights
Publisher: SPRINGERISSN: 1076-1551Frequency: 1 issue/year

MOLECULAR MEDICINE, published by SPRINGER, is a leading scholarly journal dedicated to advancing the fields of genetics and molecular biology with a focus on clinical applications. Since its inception in 1994, it has evolved to become a pivotal platform for disseminating innovative research findings, achieving a remarkable Q1 ranking in multiple categories, including Genetics, Molecular Biology, and Molecular Medicine as of 2023. Featuring an Open Access model since 2000, the journal ensures that cutting-edge research is freely available to the global scientific community, facilitating collaboration and knowledge exchange. With a commitment to high-quality peer-reviewed content, MOLECULAR MEDICINE serves as an essential resource for researchers, healthcare professionals, and students seeking to stay at the forefront of molecular research and its implications for medical science. For those interested in contributing to or accessing vital research in this dynamic field, MOLECULAR MEDICINE stands out as a premier choice.

Inflammation and Regeneration

Advancing the frontiers of immunology and regenerative medicine.
Publisher: BMCISSN: Frequency: 1 issue/year

Inflammation and Regeneration is a prominent open-access journal published by BMC, focused on the discerning fields of immunology, cell biology, and regenerative medicine. Since its establishment in 2016, the journal has provided a platform for the dissemination of high-quality research, contributing significantly to the advancement of knowledge in inflammation processes and regenerative therapies. With a remarkable impact reflected in its Q1 quartile rankings in Cell Biology and Immunology for 2023, Inflammation and Regeneration stands out as a leading resource for researchers and practitioners. The journal's commitment to open access ensures that critical findings are readily available to a global audience, fostering collaboration and innovation in the scientific community. With a Scopus ranking that places it in the top 20% of its categories, Inflammation and Regeneration serves as an essential reference for those seeking to stay at the forefront of immunological research and its applications.

CELL PROLIFERATION

Pioneering Research for a Healthier Tomorrow
Publisher: WILEYISSN: 0960-7722Frequency: 12 issues/year

CELL PROLIFERATION, published by Wiley, is a leading open-access journal that has been at the forefront of research since its inception in 1968. With an impact factor that solidifies its position in the Q1 category of both Cell Biology and Medicine (Miscellaneous), this journal serves as a premier platform for disseminating groundbreaking studies in the field of cellular and molecular biology. The journal is renowned for its rigorous peer-review process and comprehensive coverage of topics related to cell growth, division, and differentiation, making it an invaluable resource for researchers, professionals, and students alike. With its notable Scopus ranking of #30 in Biochemistry, Genetics, and Molecular Biology: Cell Biology, and a robust open access model since 2019, CELL PROLIFERATION ensures that cutting-edge research is accessible to a global audience, fostering collaboration and innovation across the scientific community. Located in the United Kingdom, the journal remains committed to enhancing the understanding of cellular processes, thereby influencing developments in medicine and biotechnology.

NEUROCHEMISTRY INTERNATIONAL

Connecting Researchers to Transform Neurochemical Understanding
Publisher: PERGAMON-ELSEVIER SCIENCE LTDISSN: 0197-0186Frequency: 10 issues/year

NEUROCHEMISTRY INTERNATIONAL, published by Pergamon-Elsevier Science Ltd, offers a premier platform for researchers and professionals in the realms of cell biology and cellular and molecular neuroscience. Established in 1980 and continuing its passion for advancing the field, this esteemed journal enhances scientific collaboration with a notable 2023 Q2 ranking in both relevant categories, placing it among the top-tier publications in its discipline with a Scopus rank of 23/97 for Cellular and Molecular Neuroscience. With its focus on groundbreaking research, the journal provides a wealth of vital data and insights that drive forward our understanding of neurochemistry and its implications in health and disease. While not an Open Access journal, NEUROCHEMISTRY INTERNATIONAL is integral for professionals, academics, and students aiming to stay at the forefront of neurobiological research innovations, making significant contributions to both academia and clinical applications.

Regenerative Engineering and Translational Medicine

Innovating Biomaterials for Tomorrow's Therapies
Publisher: SPRINGER HEIDELBERGISSN: 2364-4133Frequency: 4 issues/year

Regenerative Engineering and Translational Medicine is an esteemed academic journal published by Springer Heidelberg, focusing on the interdisciplinary fields of biomaterials, biomedical engineering, and cell biology. With an ISSN of 2364-4133 and an E-ISSN of 2364-4141, the journal has carved a niche for itself since its inception in 2015, showcasing cutting-edge research that bridges the gap between scientific findings and practical applications in regenerative medicine. As a recognized platform in its field, it is currently positioned within Q3 quartiles in biomaterials, biomedical engineering, and medicine (miscellaneous), with a Scopus ranking that reflects its growing influence among peers. The journal aims to disseminate high-quality, peer-reviewed articles that highlight advancements in regenerative engineering, further advancing both theoretical and applied research. Scholars and practitioners seeking to stay at the forefront of the ever-evolving landscape of regenerative health solutions will find invaluable insights and innovations within these pages. Join a community of leading thinkers and explore the journal's comprehensive research contributions, which are crucial for fostering partnerships between academia and industry in the quest for transformative medical solutions.

STEM CELLS AND DEVELOPMENT

Innovating Tomorrow's Therapeutics Today
Publisher: MARY ANN LIEBERT, INCISSN: 1547-3287Frequency: 24 issues/year

STEM CELLS AND DEVELOPMENT, published by Mary Ann Liebert, Inc., is a leading peer-reviewed journal dedicated to the rapidly advancing fields of stem cell biology and developmental science. With an ISSN of 1547-3287 and an E-ISSN of 1557-8534, the journal encompasses a broad range of topics central to understanding stem cells' roles in development and regeneration processes. It holds a prestigious standing within its category quartiles, ranking Q3 in Cell Biology, Q2 in Developmental Biology, and Q2 in Hematology for 2023. With its convergence from 2004 to 2024, STEM CELLS AND DEVELOPMENT fosters an innovative platform for researchers, professionals, and students to disseminate groundbreaking research, share insights, and explore novel therapeutic approaches. Open access options enhance the journal's visibility and accessibility, promoting a collaborative exchange of information among the scientific community. Positioned at the forefront of stem cell research and its applications, this journal is vital for anyone seeking to stay informed about the latest advancements and trends within these critical areas of study.

IN VITRO CELLULAR & DEVELOPMENTAL BIOLOGY-ANIMAL

Fostering Scientific Dialogue in Cellular Research
Publisher: SPRINGERISSN: 1071-2690Frequency: 10 issues/year

IN VITRO CELLULAR & DEVELOPMENTAL BIOLOGY-ANIMAL, published by SPRINGER, is a pivotal journal in the fields of cell biology and developmental biology, focusing on in vitro studies that enhance our understanding of animal cellular mechanisms and development. With an ISSN of 1071-2690 and an E-ISSN of 1543-706X, this esteemed journal offers a platform for researchers to present their findings and contribute to the body of knowledge necessary for advancements in biological sciences. As a recognized publication, it holds a 2023 category quartile of Q4 in Cell Biology and Developmental Biology, and Q3 in miscellaneous Medicine, reflecting its competitive position yet inviting critical submissions that can span multidisciplinary approaches. Though currently not open access, it serves as an essential resource for professionals, researchers, and students dedicated to unraveling the complexities of cellular processes in an ever-evolving field. The journal has been continuously published since 1986, signifying its long-standing commitment to fostering scientific discourse and innovation.

Stem Cell Reviews and Reports

Pioneering Insights in Stem Cell Therapy
Publisher: SPRINGERISSN: 2629-3269Frequency: 8 issues/year

Stem Cell Reviews and Reports is a prestigious journal published by SPRINGER specializing in the dynamic field of stem cell research, encompassing various aspects of cell biology and cancer research. With an ISSN of 2629-3269 and E-ISSN of 2629-3277, this journal serves as an essential resource for academics, offering insightful reviews and cutting-edge reports from 2009 to 2024. The journal has achieved a commendable Q2 ranking in both Cancer Research and Cell Biology categories as of 2023, highlighting its significant contribution to the scientific community. Additionally, with Scopus rankings placing it in the 74th percentile for both biochemistry and cell biology, it is recognized for its high-quality articles that foster innovative approaches in stem cell therapy and regenerative medicine. As an Open Access publication, Stem Cell Reviews and Reports ensures that its comprehensive content is readily available to researchers, professionals, and students, promoting collaboration and advancement in this vital area of study.

Stem Cell Research

Unlocking the mysteries of stem cell biology.
Publisher: ELSEVIERISSN: 1873-5061Frequency: 6 issues/year

Stem Cell Research is a premier Open Access journal published by ELSEVIER, dedicated to advancing the understanding of stem cell biology. Since its inception in 2007, the journal has provided a platform for the latest research in the fields of Cell Biology, Developmental Biology, and Medicine, with its publication being accessible globally since 2014. Located in the Netherlands, the journal’s comprehensive scope aims to bridge fundamental discoveries with clinical applications, fostering collaboration among researchers and professionals. With a 2023 impact factor reflected in its Q4 ranking in Cell and Developmental Biology and a commendable position in the 64th percentile for General Medicine, Stem Cell Research remains a vital resource for those interested in the dynamic landscape of regenerative medicine. Targeting an audience that includes researchers, practitioners, and students, the journal emphasizes not only the significance of stem cells in medical science but also the ethical considerations and the public discourse surrounding stem cell research. Join the community committed to pioneering the future of stem cell science through rigorous peer-reviewed research.

Regenerative Therapy

Transforming discoveries into impactful solutions in regenerative medicine.
Publisher: ELSEVIERISSN: 2352-3204Frequency:

Regenerative Therapy is a premier open-access journal dedicated to advancing the fields of biomaterials, biomedical engineering, and developmental biology. Published by Elsevier in Japan, this journal has been an influential platform since its inception in 2015, contributing significantly to the global discourse on regenerative medicine. With an impressive Q2 ranking in major categories such as Biomaterials and Biomedical Engineering, it is recognized for its quality of research and innovation. Researchers seeking to disseminate their findings or explore cutting-edge developments will find Regenerative Therapy to be invaluable, reflecting current trends and fostering collaborations across interdisciplinary boundaries. The journal offers open access, ensuring that high-quality research is available to a broad audience and enhances the impact of scholarly work in the regenerative medicine community.